SkylineDx and VIB Initiate Joint Research Program on Immune Prediction

ROTTERDAM, Netherlands and SAN DIEGO, Dec. 11, 2023 /PRNewswire/ — SkylineDx, an innovative molecular diagnostics company, is thrilled to announce that a collaborative project for precision medicine, POINTILLISM 2.0, has been selected for funding as part of the prestigious VIB Grand…

Click here to view original post